Literature DB >> 9379347

Bioadhesive microspheres for ophthalmic administration of acyclovir.

I Genta1, B Conti, P Perugini, F Pavanetto, A Spadaro, G Puglisi.   

Abstract

The bioavailability of acyclovir to the ophthalmic epithelium is low and when the drug is administered in ophthalmic ointment it must be applied every four hours. An emulsification technique has been used to prepare acyclovir-loaded chitosan microspheres with the aim of promoting the prolonged release of drug and increasing its ocular bioavailability. The microparticulate drug-delivery systems obtained have been characterized for their morphology and physicochemical characteristics by in-vitro dissolution tests and in-vivo ocular administration to rabbits. The results show that the microspheres obtained are always quite small--the diameters of 90% of the particles are < or = 25 microns (i.e. d 90% never exceeds 25 microns) and physicochemical characterization shows that the drug is homogeneously dispersed in an amorphous state inside the microspheres. The in-vitro dissolution profile of acyclovir from chitosan microspheres is slower than that for the raw drug. Results from in-vivo ocular administration of acyclovir-loaded microspheres to the rabbit eye show prolonged high concentrations of acyclovir and increased AUC values. The microparticulate drug-carrier seems a promising means of topical administration of acyclovir to the eye.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9379347     DOI: 10.1111/j.2042-7158.1997.tb06103.x

Source DB:  PubMed          Journal:  J Pharm Pharmacol        ISSN: 0022-3573            Impact factor:   3.765


  18 in total

Review 1.  Bioadhesion: new possibilities for drug administration?

Authors:  J Woodley
Journal:  Clin Pharmacokinet       Date:  2001       Impact factor: 6.447

Review 2.  Biodegradable implants for sustained drug release in the eye.

Authors:  Susan S Lee; Patrick Hughes; Aron D Ross; Michael R Robinson
Journal:  Pharm Res       Date:  2010-06-10       Impact factor: 4.200

Review 3.  Recent advances in intravesical drug/gene delivery.

Authors:  Pradeep Tyagi; Pao-Chu Wu; Michael Chancellor; Naoki Yoshimura; Leaf Huang
Journal:  Mol Pharm       Date:  2006 Jul-Aug       Impact factor: 4.939

4.  Mucoadhesive microspheres for gastroretentive delivery of acyclovir: in vitro and in vivo evaluation.

Authors:  Sumeet Dhaliwal; Subheet Jain; Hardevinder P Singh; A K Tiwary
Journal:  AAPS J       Date:  2008-06-04       Impact factor: 4.009

5.  Controlled ocular delivery of acyclovir through rate controlling ocular insert of Eudragit: a technical note.

Authors:  Shagufta Khan; Asgar Ali; Dilesh Singhavi; Pramod Yeole
Journal:  AAPS PharmSciTech       Date:  2008-01-25       Impact factor: 3.246

6.  Mucoadhesive microparticles in a rapidly dissolving tablet for sustained drug delivery to the eye.

Authors:  Young Bin Choy; Samirkumar R Patel; Jung-Hwan Park; Bernard E McCarey; Henry F Edelhauser; Mark R Prausnitz
Journal:  Invest Ophthalmol Vis Sci       Date:  2011-04-22       Impact factor: 4.799

7.  Evaluation of cytotoxicity and mechanism of apoptosis of doxorubicin using folate-decorated chitosan nanoparticles for targeted delivery to retinoblastoma.

Authors:  Suphiya Parveen; Sanjeeb K Sahoo
Journal:  Cancer Nanotechnol       Date:  2010-10-25

8.  Influence of preparation conditions on acyclovir-loaded poly-d,l-lactic acid nanospheres and effect of PEG coating on ocular drug bioavailability.

Authors:  Claudia Giannavola; Claudio Bucolo; Adriana Maltese; Donatella Paolino; Maria Angela Vandelli; Giovanni Puglisi; Vinecent H L Lee; Massimo Fresta
Journal:  Pharm Res       Date:  2003-04       Impact factor: 4.200

9.  Mucoadhesive microdiscs engineered for ophthalmic drug delivery: effect of particle geometry and formulation on preocular residence time.

Authors:  Young Bin Choy; Jung-Hwan Park; Bernard E McCarey; Henry F Edelhauser; Mark R Prausnitz
Journal:  Invest Ophthalmol Vis Sci       Date:  2008-08-08       Impact factor: 4.799

10.  Chitosan nanoparticles as new ocular drug delivery systems: in vitro stability, in vivo fate, and cellular toxicity.

Authors:  Angela M de Campos; Yolanda Diebold; Edison L S Carvalho; Alejandro Sánchez; Maria José Alonso
Journal:  Pharm Res       Date:  2004-05       Impact factor: 4.200

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.